Balasa Dinverno & Foltz’s Vertex Pharmaceuticals VRTX Stock Holding History

Balasa Dinverno & Foltz’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.17M	Buy
2022 Q2	$544K	Buy
2021 Q1	–	Sell
2020 Q4	$233K	Sell
2020 Q3	$681K	Sell
2020 Q2	$948K	Buy
2020 Q1	$386K	Buy